Autism Research Project With Non-Invasive Near-Infrared Light Stimulation
ConditionAutism Spectrum Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-60
SponsorFrancisco Gonzalez-Lima, PhD
About this trial
The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 4-60 years
Disqualifiers
Current pregnancy
Trial design
Design model
Factorial
Treatments tested in this trial
Transcranial infrared light stimulation
DeviceTrancranial infrared light stimulation administered via light-emitting diodes
Sham
DeviceIdentical to TILS, but with lights off
Treatment groups
280 Participants
are divided into 2 treatment groupsGroup A: TILS-treatedExperimental treatment 1 intervention
Group B: ShamSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Autism spectrum questionnaires
Assess individual differences and changes in autistic traits
Time frame
Up to two monthsSecondary outcomes
1
Functional near-infrared spectroscopy
Brain resting state and activational state measures
Time frame
Up to two months2
Continuous Performance Task
Measure of inattention, impulsivity, sustained attention, vigilance
Time frame
Up to two monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Francisco Gonzalez-Lima, PhD
Lead sponsor
University of Texas at Austin
Sponsor institution
Source ClinicalTrials.gov